First participants enrolled in clinical trial received Omicron-based vaccine candidate as a two-dose primary series and as a booster dose.
Drugs and pharma giants Pfizer...
Omicron has a substantial growth advantage over the Delta strain of COVID-19 and is rapidly replacing Delta globally, particularly because it is able to...
Relying solely on the Chinese-manufactured Sinovac inactive vaccine is not enough to reduce transmission rates of COVID-19. Millions of people in 48 countries around...
While a single monthly reading above 6 per cent does not constitute a formal policy failure, the persistent upward trajectory since early 2026 leaves monetary authorities with little room to manoeuvre.
The authors stress that individual knowledge alone is insufficient. Food environments – marketing, pricing, availability and access – must support healthier choices.
While a single monthly reading above 6 per cent does not constitute a formal policy failure, the persistent upward trajectory since early 2026 leaves monetary authorities with little room to manoeuvre.